The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Mortality in the catastrophic antiphospholipid syndrome: Causes of death and prognostic factors in a series of 250 patients
Abstract
Objective: To assess the main causes of death and the prognostic factors that influence mortality in patients with the catastrophic antiphospholipid syndrome (CAPS). Methods: We analyzed the case reports of 250 patients included in the CAPS Registry up to February 2005. To identify prognostic factors for CAPS, we compared the main clinical and immunologic features and the types of treatment in the patients who died with those features in the patients who survived. Results: Recovery occurred in 56% of the episodes of CAPS and death occurred in 44%. Cerebral involvement, consisting mainly of stroke, cerebral hemorrhage, and encephalopathy, was considered the main cause of death, being present in 27.2% of patients, followed by cardiac involvement (19.8%) and infection (19.8%). The only factor we identified that was prognostic of a higher mortality rate was the presence of systemic lupus erythematosus (SLE). A higher recovery rate was associated with combined treatment with anticoagulants (ACs) plus corticosteroids (CS) plus plasma exchange (PE) (77.8%), followed by ACs plus CS plus PE and/or intravenous immunoglobulins (69%). In contrast, concomitant treatment with cyclophosphamide did not demonstrate additional benefit. Conclusion: Cerebral involvement (mainly consisting of stroke), cardiac involvement, and infections were considered the main causes of death in patients with CAPS. The presence of SLE was related to a higher mortality rate. According to the results of the present study, ACs plus CS plus PE should be the first line of therapy in patients with CAPS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cervera, R., Piette, J., Font, J., Khamashta, M. A., Shoenfeld, Y., Camps, M. T., Jacobsen, S., Lakos, G., Tincani, A., Kontopoulou‐Griva, I., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10187 · Cited by 2,156
Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome
Bhatia, M., & Moochhala, S. (2004) · The Journal of Pathology · doi:10.1002/path.1491 · Cited by 1,095
Asherson, R. A., Cervera, R., de Groot, P. G., Erkan, D., Boffa, M.-C., Piette, J.-C., Khamashta, M. A., Shoenfeld, Y., & Catastrophic Antiphospholipid Syndrome Registry Project Group (2003) · Lupus · doi:10.1191/0961203303lu394oa · Cited by 865
Self-citationCatastrophic Antiphospholipid Syndrome: Clinical and Laboratory Features of 50 Patients
Asherson, R. A., Cervera, R., Piette, J.-C., Font, J., Lie, J. T., Burcoglu, A., Lim, K., Muñoz-Rodríguez, F. J., Levy, R. A., Boué, F., et al. (1998) · Medicine · doi:10.1097/00005792-199805000-00005 · Cited by 544
Self-citationCatastrophic Antiphospholipid Syndrome: Clues to the Pathogenesis from a Series of 80 Patients
ASHERSON, R. A., CERVERA, R., PIETTE, J.-C., SHOENFELD, Y., ESPINOSA, G., PETRI, M. A., LIM, E., LAU, T. C., GURJAL, A., JEDRYKA-GÓRAL, A., et al. (2001) · Medicine · doi:10.1097/00005792-200111000-00002 · Cited by 388
Self-citationSepsis and the systemic inflammatory response syndrome: Neuromuscular manifestations
Bolton, C. F. (1996) · Critical Care Medicine · doi:10.1097/00003246-199608000-00022 · Cited by 271
Meroni, P. L., Raschi, E., Camera, M., Testoni, C., Nicoletti, F., Tincani, A., Khamashta, M. A., Balestrieri, G., Tremoli, E., & Hess, D. C. (2000) · Journal of Autoimmunity · doi:10.1006/jaut.2000.0412 · Cited by 163
Long term outcome of catastrophic antiphospholipid syndrome survivors
Erkan, D., Asherson, R. A., Espinosa, G., Cervera, R., Font, J., Pietté, J. C., & Lockshin, M. D. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.6.530 · Cited by 156
Self-citationBurcoglu-O'Ral, A., Erkan, D., & Asherson, R. A. (2002) · PubMed · Cited by 82
Self-citationThe catastrophic antiphospholipid syndrome--Asherson's syndrome.
Pietté, J. C., Cervera, R., Levy, R. A., Nasonov, E. L., Triplett, D. A., & Shoenfeld, Y. (2003) · PubMed · Cited by 72
Self-citation
Cited by
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
Rovin, B. H., Adler, S. G., Barratt, J., Bridoux, F., Burdge, K. A., Chan, T. M., Cook, H. T., Fervenza, F. C., Gibson, K. L., Glassock, R. J., et al. (2021) · Kidney International · doi:10.1016/j.kint.2021.05.021 · Cited by 2,518
Padmanabhan, A., Connelly‐Smith, L., Aqui, N., Balogun, R. A., Klingel, R., Meyer, E., Pham, H. P., Schneiderman, J., Witt, V., Wu, Y., et al. (2019) · Journal of Clinical Apheresis · doi:10.1002/jca.21705 · Cited by 2,230
Cervera, R., Serrano, R., Pons-Estel, G. J., Ceberio-Hualde, L., Shoenfeld, Y., de Ramón, E., Buonaiuto, V, Jacobsen, S., Zeher, M. M., Tarr, T., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204838 · Cited by 974
Self-citationConnelly‐Smith, L., Alquist, C. R., Aqui, N. A., Hofmann, J. C., Klingel, R., Onwuemene, O. A., Patriquin, C. J., Pham, H. P., Sanchez, A. P., Schneiderman, J., et al. (2023) · Journal of Clinical Apheresis · doi:10.1002/jca.22043 · Cited by 684
Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19
Zuo, Y., Estes, S. K., Ali, R. A., Gandhi, A. A., Yalavarthi, S., Shi, H., Sule, G., Gockman, K., Madison, J. A., Zuo, M., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.abd3876 · Cited by 660
KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS
Rovin, B. H., Ayoub, I. M., Chan, T. M., Liu, Z.-H., Mejía-Vilet, J. M., & Floege, J. (2024) · Kidney International · doi:10.1016/j.kint.2023.09.002 · Cited by 517
Mosca, M., Tani, C., Aringer, M., Bombardieri, S., Boumpas, D., Brey, R., Cervera, R., Doria, A., Jayne, D., Khamashta, M. A., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.117200 · Cited by 377
Self-citationCervera, R., Bucciarelli, S., Plasín, M. A., Gómez-Puerta, J. A., Plaza, J., Pons-Estel, G., Shoenfeld, Y., Ingelmo, M., & Espinos, G. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.02.008 · Cited by 358
Self-citationCervera, R., Khamashta, M. A., Shoenfeld, Y., Camps, M. T., Jacobsen, S., Kiss, E., Zeher, M. M., Tincani, A., Kontopoulou-Griva, I., Galeazzi, M., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.093179 · Cited by 286
Self-citationBerman, H., Rodríguez-Pintó, I., Cervera, R., Morel, N., Costedoat-Chalumeau, N., Erkan, D., Shoenfeld, Y., & Espinosa, G. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.05.004 · Cited by 259
Self-citation
Metadata
- Authors
- Bucciarelli, S., Espinosa, G., Cervera, R., Erkan, D., Gómez‐Puerta, J. A., Ramos‐Casals, M., Font, J., & Asherson, R. A.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2006-07-25
- Volume
- 54
- Issue
- 8
- Pages
- 2568-2576
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2030933556
- Cited by
- 334
- References
- 15
- FWCI
- 12.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.